Your Health, We Care
Different types of urothelial carcinoma may respond differently to medications, and the staging determines the urgency of treatment and the choice of regimen.
Many drugs targeting urothelial carcinoma are targeted, such as drugs that target receptors such as EGFR and VEGFR.
The efficacy and side effects of these drugs are closely related to the targeting of the drugs. When using these drugs, special attention needs to be paid to the targeting of the drugs and the possible adverse effects.
Drugs used to treat urothelial carcinoma may have an impact on kidney function. During treatment, patients need to monitor renal function indicators regularly so that abnormal kidney function can be detected and managed in a timely manner.
Some drugs for urothelial carcinoma need to be given by intravenous infusion, and some drugs may need to be given slowly to reduce the occurrence of adverse effects.
During the infusion, it is necessary to pay attention to the method and speed of the infusion of the drug.
